title: Fatal hyperacute graft-versus-host disease following denileukin diftitox treatment for recurrent t cell lymphoma after allogeneic stem cell transplantation.
authors.forename: Sapna
authors.initials: S
authors.lastname: Khubchandani
authors.forename: George
authors.initials: G
authors.lastname: Deeb
authors.forename: Shannon L
authors.initials: SL
authors.lastname: Smiley
authors.forename: Minoo
authors.initials: M
authors.lastname: Battiwalla
authors.forename: Pamela
authors.initials: P
authors.lastname: Paplham
authors.forename: Karen
authors.initials: K
authors.lastname: Brown
authors.forename: Margaret
authors.initials: M
authors.lastname: Syta
authors.forename: Theresa
authors.initials: T
authors.lastname: Hahn
authors.forename: Richard
authors.initials: R
authors.lastname: Cheney
authors.forename: Philip L
authors.initials: PL
authors.lastname: McCarthy
authors.forename: Frederick
authors.initials: F
authors.lastname: Hong
mesh_terms: D000208:Acute Disease; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D004167:Diphtheria Toxin / Q000008:administration & dosage*; D017809:Fatal Outcome; D006086:Graft vs Host Disease / Q000188:drug therapy*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007376:Interleukin-2 / Q000008:administration & dosage*; D016399:Lymphoma, T-Cell / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011993:Recombinant Fusion Proteins / Q000008:administration & dosage; D014184:Transplantation, Homologous
chemical_list: D000970:Antineoplastic Agents; D004167:Diphtheria Toxin; D007376:Interleukin-2; D011993:Recombinant Fusion Proteins; C078456:denileukin diftitox